| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Axsome Therapeutics, Inc. (AXSM) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. AXSM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 57.5K | $13.56M | - | |
| Dir | 48.2K | $11.37M | - | |
| CEO | 24.1K | $5.68M | - | |
| COO | 8.7K | $2.04M | - | |
| CFO | 8.2K | $1.93M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Coleman Mark | Director | Sell | 3,000 | $107.49 | $322,473.00 | -5.3% | +2.6% | - | |
| Feb 14, 2025 | Pizzie Nick50 | Chief Financial Officer | Sale+OE | 15,000 | $130.10 | $1,951,530.00 | -15.1% | -18.2% | +38.2% | |
| Sep 11, 2024 | Saad Mark E50 | Director | Sale+OE | 11,016 | $91.31 | $1,005,870.96 | -52.4% | +8.6% | +35.1% | |
| Aug 9, 2024 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 47,739 | $84.26 | $4,022,488.14 | -89.2% | +9.2% | +26.1% | |
| May 29, 2024 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 7,910 | $74.31 | $587,813.46 | -57.8% | +18.2% | +39.1% | |
| May 29, 2024 | Coleman Mark | Director | Sell | 10,497 | $75.17 | $789,107.29 | -23.4% | +18.2% | +39.1% | |
| Apr 1, 2024 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 24,662 | $77.24 | $1,904,942.20 | -100% | +5.2% | +45.0% | |
| Mar 15, 2024 | Jeffs Roger67 | Director | Sale+OE | 32,323 | $69.84 | $2,257,449.25 | -8.2% | -4.0% | +61.4% | |
| Sep 15, 2023 | Coleman Mark | Director | Sale+OE | 29,588 | $75.18 | $2,224,430.37 | -6.5% | -2.6% | +24.5% | |
| Nov 19, 2021 | Jeffs Roger67 | Director | Buy | 3,950 | $37.30 | $147,350.01 | +3.4% | -15.1% | +56.9% |